Terpenoid ID | TKC122982 | |
Cell line | 0 | |
Protein target | 2 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 1 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC122982 | A549 | 98200.0 | nM | IC50 | C3512 | ||
TKC122982 | PC-3 | PC3; PC.3 | 18280.0 | nM | IC50 | C4863 | |
TKC122982 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 22730.0 | nM | IC50 | C4863 | |
TKC122982 | MCF7 | 21430.0 | nM | IC50 | C4194 | ||
TKC122982 | MDA-MB-231 | MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 | 564000.0 | nM | IC50 | C5214 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC122982 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 103 | % | Inhibition |
TKC122982 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 110 | % | Inhibition |
TKC122982 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | IDH1 | 101 | % | Activity |
TKC122982 | P0DTD1 | Replicase polyprotein 1ab | rep | 11 | % | Inhibition |
TKC122982 | Q9WKE8 | Reverse transcriptase | reverse transcriptase | >200 | ug.mL-1 | IC50 |
TKC122982 | Q9F4F7 | 4'-phosphopantetheinyl transferase ffp | ffp | 56234 | nM | Potency |
TKC122982 | P06746 | DNA polymerase beta | POLB | 43400 | nM | IC50 |
TKC122982 | P06766 | DNA polymerase beta | Polb | >500000 | nM | IC50 |
TKC122982 | P09884 | DNA polymerase alpha catalytic subunit | POLA1 | >500000 | nM | IC50 |
TKC122982 | P11388 | DNA topoisomerase 2-alpha | TOP2A | >500000 | nM | IC50 |
TKC122982 | P34969 | 5-hydroxytryptamine receptor 7 | HTR7 | 0 | % | Inhibition |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 | IDHC_HUMAN | Liver cancer [ICD-11: 2C12] |
O75874 | IDHC_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P06746 | DPOLB_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P09884 | DPOLA_HUMAN | Virus infection [ICD-11: 1A24-1D9Z] |
P11388 | TOP2A_HUMAN | Kaposi sarcoma [ICD-11: 2B57] |
P11388 | TOP2A_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11388 | TOP2A_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P11388 | TOP2A_HUMAN | Mature T-cell lymphoma [ICD-11: 2A90] |
P34969 | 5HT7R_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P34969 | 5HT7R_HUMAN | Attention deficit hyperactivity disorder [ICD-11: 6A05] |
P34969 | 5HT7R_HUMAN | Bipolar disorder [ICD-11: 6A60] |
P34969 | 5HT7R_HUMAN | Depression [ICD-11: 6A70-6A7Z] |
P34969 | 5HT7R_HUMAN | Mild neurocognitive disorder [ICD-11: 6D71] |
P34969 | 5HT7R_HUMAN | Parkinsonism [ICD-11: 8A00] |
P34969 | 5HT7R_HUMAN | Schizophrenia [ICD-11: 6A20] |
P34969 | 5HT7R_HUMAN | Sleep-wake disorder [ICD-11: 7A00-7B2Z] |
P34969 | 5HT7R_HUMAN | Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |